SCHEMBL6326964

SCHEMBL6326964

N#Cc1ccc(OCc2ccccc2)c(C(N)c2ccnc3cc(C(=O)N4CCCC4)ccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.46
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HPGD P15428 4/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
CDK1 P06493 1/20 0.41
HAT1 O14929 1/20 0.40
EP300 Q09472 1/20 0.40
MGLL Q99685 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321682 0.85 ALDH1A1 (0.43) KDM1AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL6324855 0.84 CDK8 (0.41) KDM1AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL6326969 0.80 CDK8 (0.46) KDM1AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL6331290 0.80 CDK1 (0.48) KDM1AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL6331414 0.80 HPGD (0.45) CYP3A4HPGDCDK1HAT1EP300
SCHEMBL6332084 0.79 SLC6A9 (0.43) KDM1AHSD17B10NPC1RAB9ACDK1
SCHEMBL6326781 0.76 SLC6A9 (0.43) KDM1AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6331440 0.74 CDK1 (0.46) KDM1AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL6321686 0.72 CDK1 (0.44) KDM1AALDH1A1CYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL6329967 0.72 HPGD (0.41) ALDH1A1HSD17B10HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions F12, F2, F11 KDM1A 1406/4885ALDH1A1 1078/4885CYP1A2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.